About Trefoil Therapeutics
Trefoil Therapeutics develops engineered fibroblast growth factor (FGFR) therapeutics for ocular surface diseases including corneal endothelial dysfunction.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Trefoil Therapeutics. Response typically within 48 hours.
